Charcot JM. Sur une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteingnant plus tard les mains. Rev Med. 1886. 6:97-138.
Tooth HH. The peroneal type of progressive muscular atrophy. London, England: Lewis. 1886.
Dejerine H, Sottas J. Sur la nevrite interstitielle, hypertrophique et progressive de l'enfance. CR Soc Biol (Paris). 1893. 45:63-96.
Roussy G, Levy G. A sept cas d'une maladie familiale particulaire. Rev Neurol. 1926. 33:427-50.
Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol. 1968 Jun. 18(6):603-18. [Medline].
Kleopa KA, Scherer SS. Inherited neuropathies. Neurol Clin. 2002 Aug. 20(3):679-709. [Medline].
Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology. 2003 Jan 14. 60(1):22-6. [Medline].
Emery AE. Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord. 1991. 1(1):19-29. [Medline].
Meretoja P, Silander K, Kalimo H, et al. Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in south western Finland. Neuromuscul Disord. 1997 Dec. 7(8):529-32. [Medline].
Kurihara S, Adachi Y, Wada K, et al. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology. 2002 Sep-Oct. 21(5):246-50. [Medline].
Thomas FP, Oliveira GR. Hereditary neuropathy with predisposition to pressure palsy. In: Gilman S, ed. Medlink Neurology. 4th ed. San Diego, Calif:. Medlink Corporation. 2001:Available at: www.medlink.com.
Lin KP, Soong BW, Yang CC, Huang LW, Chang MH, Lee IH, et al. Correction: The Mutational Spectrum in a Cohort of Charcot-Marie-Tooth Disease Type 2 among the Han Chinese in Taiwan. PLoS One. 2012. 7(1):[Medline]. [Full Text].
Vucic S, Kennerson M, Zhu D, et al. CMT with pyramidal features. Charcot-Marie-Tooth. Neurology. 2003 Feb 25. 60(4):696-9. [Medline].
Phillips MF, Robertson Z, Killen B, White B. A pilot study of a crossover trial with randomized use of ankle-foot orthoses for people with Charcot-Marie-Tooth disease. Clin Rehabil. 2011 Nov 16. [Medline].
Thomas PK, Marques W Jr, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain. 1997 Mar. 120 ( Pt 3):465-78. [Medline].
Auer-Grumbach M, Wagner K, Strasser-Fuchs S, et al. Clinical predominance of proximal upper limb weakness in CMT1A syndrome. Muscle Nerve. 2000 Aug. 23(8):1243-9. [Medline].
Dematteis M, Pepin JL, Jeanmart M, et al. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet. 2001 Jan 27. 357(9252):267-72. [Medline].
Verhoeven K, De Jonghe P, Coen K. Mutations in the Small GTP-ase Late Endosomal Protein RAB7 Cause Charcot-Marie-Tooth Type 2B Neuropathy. Am J Hum Genet. 2003. 72:722-7. [Medline].
Ismailov SM, Fedotov VP, Dadali EL, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet. 2001 Aug. 9(8):646-50. [Medline].
Jacob JC, Andermann F, Robb JP. Heredofamilial neuritis with brachial predilection. Neurology. 1961 Dec. 11:1025-33. [Medline].
Guillozet N, Mercer RD. Hereditary recurrent brachial neuropathy. Am J Dis Child. 1973 Jun. 125(6):884-7. [Medline].
Blyton F, Ryan MM, Ouvrier RA, Burns J. Muscle cramp in pediatric Charcot-Marie-Tooth disease type 1A: prevalence and predictors. Neurology. 2011 Dec 13. 77(24):2115-8. [Medline]. [Full Text].
Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet. 2010 Feb. 42(2):170-4. [Medline]. [Full Text].
Motley WW, Seburn KL, Nawaz MH, Miers KE, Cheng J, Antonellis A, et al. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet. 2011 Dec. 7(12):e1002399. [Medline]. [Full Text].
Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, et al. Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A. Neuromuscul Disord. 2008 Aug. 18(8):610-8. [Medline].
Behse F, Buchthal F, Carlsen F, Knappeis GG. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain. 1972. 95(4):777-94. [Medline].
Madrid R, Bradley WG. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy). J Neurol Sci. 1975. 25:415-48.
Gabreels-Festen A, Wetering RV. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene. Ann N Y Acad Sci. 1999 Sep 14. 883:336-43. [Medline].
Sander S, Ouvrier RA, McLeod JG, et al. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry. 2000 Apr. 68(4):483-8. [Medline].
Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ, Fahey MC, et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 2009 Jun. 8(6):537-44. [Medline].
Antognini JF. Anaesthesia for Charcot-Marie-Tooth disease: a review of 86 cases. Can J Anaesth. 1992 Apr. 39(4):398-400. [Medline].
Benstead TJ, Grant IA. Progress in clinical neurosciences: Charcot-Marie-Tooth disease and related inherited peripheral neuropathies. Can J Neurol Sci. 2001 Aug. 28(3):199-214. [Medline].
Bergoffen J, Scherer SS, Wang S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993 Dec 24. 262(5142):2039-42. [Medline].
Bolino A, Brancolini V, Bono F, et al. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet. 1996 Jul. 5(7):1051-4. [Medline].
Briani C, Adami F, Cavallaro T, Taioli F, Ferrari S, Fabrizi G. Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy. Muscle Nerve. 2008 Jul. 38(1):921-3. [Medline].
Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord. 2003 Jan. 13(1):60-7. [Medline].
Chung KW, Kim SB, Park KD, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain. 2006 Aug. 129(Pt 8):2103-18. [Medline].
De Jonghe P, Mersivanova I, Nelis E, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol. 2001 Feb. 49(2):245-9. [Medline].
Fabrizi GM, Cavallaro T, Angiari C, et al. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain. 2006 Oct 18. [Medline].
Gallardo E, Garcia A, Combarros O, Berciano J. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain. 2006 Feb. 129(Pt 2):426-37. [Medline].
Gondim FA, Thomas FP. Charcot-Marie-Tooth disease type 1A. In: Gilman S, ed. Medlink Neurology. 4th ed. San Diego, Calif:. MedLink Corporation. 2001:Available at: www.medlink.com.
Hahn AF, Bolton CF, White CM. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. Ann N Y Acad Sci. 1999 Sep 14. 883:366-82. [Medline].
Hahn AF, Brown WF, Koopman WJ, et al. X-linked dominant hereditary motor and sensory neuropathy. Brain. 1990 Oct. 113 ( Pt 5):1511-25. [Medline].
Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain. 1980 Jun. 103(2):259-80. [Medline].
Houlden H, Laura M, Wavrant-De Vrièze F, Blake J, Wood N, Reilly MM. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology. 2008 Oct 1. [Medline].
Ionasescu VV, Ionasescu R, Searby C. Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve. 1993 Nov. 16(11):1232-8. [Medline].
Jeannet PY, Watts GD, Bird TD, Chance PF. Craniofacial and cutaneous findings expand the phenotype of hereditary neuralgic amyotrophy. Neurology. 2001 Dec 11. 57(11):1963-8. [Medline].
Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet. 2006. 38:197-202. [Medline].
Kalaydjieva L, Gresham D, Gooding R, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet. 2000 Jul. 67(1):47-58. [Medline].
Kennerson ML, Zhu D, Gardner RJ, et al. Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. Am J Hum Genet. 2001 Oct. 69(4):883-8. [Medline].
Kim HJ, Sohn KM, Shy ME, Krajewski KM, Hwang M, Park JH, et al. Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5). Am J Hum Genet. 2007 Sep. 81(3):552-8. [Medline].
Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000 Jul. 67(1):37-46. [Medline].
Meuleman J, Timmerman V, Van Broeckhoven C, De Jonghe P. Hereditary neuralgic amyotrophy. Neurogenetics. 2001 Jul. 3(3):115-8. [Medline].
Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology. 1999 Apr 22. 52(7):1440-6. [Medline].
Muglia M, Zappia M, Timmerman V, et al. Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. Neurology. 2001 Jan 9. 56(1):100-3. [Medline].
Nave KA, Sereda MW, Ehrenreich H. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. Nat Clin Pract Neurol. 2007 Aug. 3(8):453-64. [Medline].
Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology. 1993 Dec. 43(12):2558-64. [Medline].
Ochoa J, Danta G, Fowler TJ, Gilliatt RW. Nature of the nerve lesion caused by a pneumatic tourniquet. Nature. 1971 Sep 24. 233(5317):265-6. [Medline].
Pareyson D, Schenone A, Fabrizi GM, et al. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res. 2006 Dec. 54(6):436-41. [Medline].
Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004 Apr. 10(4):396-401. [Medline].
Pelayo-Negro AL, Gallardo E, García A, Sánchez-Juan P, Infante J, Berciano J. Evolution of Charcot-Marie-Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study. J Neurol. 2014 Jan 22. [Medline].
Plante-Bordeneuve V, Guiochon-Mantel A, Lacroix C, et al. The Roussy-Levy family: from the original description to the gene. Ann Neurol. 1999 Nov. 46(5):770-3. [Medline].
Plante-Bordeneuve V, Said G. Dejerine-Sottas disease and hereditary demyelinating polyneuropathy of infancy. Muscle Nerve. 2002 Nov. 26(5):608-21. [Medline].
Ramchandren S, Jaiswal M, Feldman E, Shy M. Effect of pain in pediatric inherited neuropathies. Neurology. 2014 Jan 29. [Medline].
Reilly ME, Mantle D, Richardson PJ, et al. Studies on the time-course of ethanol's acute effects on skeletal muscle protein synthesis: comparison with acute changes in proteolytic activity. Alcohol Clin Exp Res. 1997 Aug. 21(5):792-8. [Medline].
Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol. 2013 Oct. 9(10):562-71. [Medline].
Sereda MW, Meyer zu Horste G, Suter U, et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003 Dec. 9(12):1533-7. [Medline].
Sevilla T, Jaijo T, Nauffal D, Collado D, Chumillas MJ, Vilchez JJ, et al. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy. Brain. 2008 Sep 23. [Medline].
Sevilla T, Jaijo T, Nauffal D, Collado D, Chumillas MJ, Vilchez JJ, et al. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy. Brain. 2008 Sep 23. [Medline].
Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth''s disease. Clin Genet. 1974. 6(2):98-118. [Medline].
Steiner I, Gotkine M, Steiner-Birmanns B, Biran I, Silverstein S, Abeliovich D, et al. Increased severity over generations of Charcot-Marie-Tooth disease type 1A. J Neurol. 2008 Jun. 255(6):813-9. [Medline].
Thomas FP, Geller TJ, Hahn AF, et al. Modification of CMT1 phenotypes by the independent coexisting neurogenetic disorders, McArdle disease and chromosome 5p trisomy. Ann N Y Acad Sci. 1999 Sep 14. 883:472-6. [Medline].
Thomas FP, Gondim FA. Charcot-Marie-Tooth Disease Type 1B and mutations of the myelin protein zero. Clinical spectrum and pathogenic mechanisms. In: Gilman S, ed. Medlink Neurology. 3rd ed. San Diego, Calif:. MedLink Corporation. 2001:Available at: www.medlink.com.
Tyson J, Malcolm S, Thomas PK, Harding AE. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann Neurol. 1996 Feb. 39(2):180-6. [Medline].
Verhoeven K, Villanova M, Rossi A, et al. Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1. Am J Hum Genet. 2001 Oct. 69(4):889-94. [Medline].
Vinci P, Esposito C, Perelli SL, et al. Overwork weakness in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil. 2003 Jun. 84(6):825-7. [Medline].
Warner LE, Hilz MJ, Appel SH, et al. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996 Sep. 17(3):451-60. [Medline].
Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet. 1998 Apr. 18(4):382-4. [Medline].
Zambelis T, Panas M, Kokotis P, Karadima G, Kararizou E, Karandreas N. Central motor and sensory pathway involvement in an X-linked Charcot-Marie-Tooth family. Acta Neurol Belg. 2008 Jun. 108(2):44-7. [Medline].
Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 2001 Jun 1. 105(5):587-97. [Medline].
Zuchner S, Vance JM. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat Clin Pract Neurol. 2006. 2:45-53. [Medline].